- Home
- GEHC
as 05-30-2025 11:36am EST
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
| Founded: | 1892 | Country: | United States |
| Employees: | N/A | City: | CHICAGO |
| Market Cap: | 28.1B | IPO Year: | N/A |
| Target Price: | $88.80 | AVG Volume (30 days): | 4.4M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 10 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 4.76 | EPS Growth: | 38.77 |
| 52 Week Low/High: | $57.65 - $94.80 | Next Earning Date: | 04-30-2025 |
| Revenue: | $19,799,000,000 | Revenue Growth: | 1.56% |
| Revenue Growth (this year): | 5.12% | Revenue Growth (next year): | 4.69% |
Latest GE HealthCare Technologies Inc. News
GEHC Breaking Stock News: Dive into GEHC Ticker-Specific Updates for Smart Investing
Business Wire
3 hours ago
Updated NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Recommend Use of FES PET Imaging for Lobular Breast Cancer
Argus Research
5 hours ago
Daily Spotlight: Fed's Favorite Inflation Indicator Out Today
Simply Wall St.
9 days ago
Should Weakness in GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Simply Wall St.
14 days ago
Following a 10% decline over last year, recent gains may please GE HealthCare Technologies Inc. (NASDAQ:GEHC) institutional owners
Business Wire
15 days ago
GE HealthCare launches CleaRecon DL, introducing AI-based 3D reconstruction to the interventional suite
TipRanks
16 days ago
GE HealthCare gets FDA approval for Optison ultrasound enhancing agent
Business Wire
17 days ago
GE HealthCare Announces FDA Approval of Pediatric Indication for Optison Ultrasound Enhancing Agent
Business Wire
17 days ago
GE HealthCare and Raydiant Oximetry accelerate innovation in fetal oxygen saturation technology
Compare GEHC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "GEHC GE HealthCare Technologies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.